The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice

被引:0
|
作者
A. Tsuchida
T. Nakagawa
Y. Itakura
J. Ichihara
W. Ogawa
M. Kasuga
M. Taiji
H. Noguchi
机构
[1] Sumitomo Pharmaceuticals,
[2] Osaka,undefined
[3] Japan,undefined
[4] The Second Department of Internal Medicine,undefined
[5] Kobe University School of Medicine,undefined
[6] Kobe,undefined
[7] Japan,undefined
来源
Diabetologia | 2001年 / 44卷
关键词
Keywords Neurotrophic factor; insulin responsiveness; glucose uptake; diabetic mice; insulin signalling.;
D O I
暂无
中图分类号
学科分类号
摘要
Aim/hypothesis. We previously reported that repeated subcutaneous or intracerebroventricular injection of brain-derived neurotrophic factor (BDNF) reduces blood glucose concentrations in obese diabetic C57BL/KsJ-db/db mice. In this study, we assessed the effects of BDNF on insulin action in peripheral tissues of diabetic mice. Methods. First, brain-derived neurotrophic factor (20 mg/kg) was subcutaneously given to male db/db mice for 14 days and then the insulin-stimulated tyrosine phosphorylation of insulin receptors and insulin-stimulated phosphatidylinositol (PI) 3-kinase activity in peripheral tissues was assessed. Second, we examined the effects of a single subcutaneous or intracerebroventricular brain-derived neurotrophic factor injection on insulin responsiveness in liver and skeletal muscle of streptozotocin (STZ)-induced diabetic mice. Third, the effects of brain-derived neurothrophic factor on insulin action were also examined in cultured cells. Results. Repeated injection of BDNF to db/db mice for 14 days enhanced insulin-stimulated tyrosine phosphorylation of insulin receptors in liver and insulin-stimulated PI 3-kinase activity in liver, skeletal muscle and interscapular brown adipose tissue. We then examined the rapid effect of BDNF on insulin signalling in vivo. A single subcutaneous or intracerebroventricular injection of BDNF rapidly increased insulin-stimulated tyrosine phosphorylation of insulin receptors and PI 3-kinase activity in liver of STZ-mice. No direct effect of brain-derived neurothrophic factor was observed on insulin signalling in primary cultured hepatocytes, L6 muscle cells or 3T3-L1 adipocytes. Brain-derived neurothrophic factor did not affect either glucose uptake or gluconeogenesis in these cells. Conclusion/interpretation. These data indicate that brain-derived neurothrophic factor rapidly enhances insulin signal transduction in liver and shows hypoglycaemic action in diabetic mice. [Diabetologia (2001) 44: 555–566]
引用
收藏
页码:555 / 566
页数:11
相关论文
共 24 条
  • [21] Plasma Concentration of Irisin and Brain-Derived-Neurotrophic Factor and Their Association With the Level of Erythrocyte Adenine Nucleotides in Response to Long-Term Endurance Training at Rest and After a Single Bout of Exercise
    Rodziewicz, Ewa
    Krol-Zielinska, Magdalena
    Zielinski, Jacek
    Kusy, Krzysztof
    Ziemann, Ewa
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [22] Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function
    Kim, J. -H.
    Bae, K. -H.
    Choi, Y. -K.
    Go, Y.
    Choe, M.
    Jeon, Y. -H.
    Lee, H. -W.
    Koo, S. -H.
    Perfield, J. W., II
    Harris, R. A.
    Lee, I. -K.
    Park, K. -G.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02): : 161 - 169
  • [23] Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice
    Nio, Y.
    Yamauchi, T.
    Iwabu, M.
    Okada-Iwabu, M.
    Funata, M.
    Yamaguchi, M.
    Ueki, K.
    Kadowaki, T.
    DIABETOLOGIA, 2012, 55 (12) : 3350 - 3358
  • [24] Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice
    Y. Nio
    T. Yamauchi
    M. Iwabu
    M. Okada-Iwabu
    M. Funata
    M. Yamaguchi
    K. Ueki
    T. Kadowaki
    Diabetologia, 2012, 55 : 3350 - 3358